P

resident Trump wants the Food and Drug Administration to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of medications that reached the market from 2001 through 2010 had major safety issues years after they became widely available to patients.

Seventy-one of these 222 drugs were withdrawn, required a “black box” warning about serious side effects, or warranted a safety announcement about new risks to the public, Yale professor Dr. Joseph Ross and his colleagues reported in JAMA on Tuesday. The study included safety actions through Feb. 28.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Wow! To say the least? I take many ssri’s and an atypical anticycotic. For depression anxiety and OCD. Now im going to do more reaserch but this is very unsettling. I dont want to die early because of a med. But I still know the benifbenefits these drugs have given me. A big dilemma. It seems like alot of government agency’s are not doing a good job these days? I just wish that they could have cot these negative side effects sooner before releasing then to the public. There’s already enough negative side effects to begin with. Now you have more side effects to look forword to. Thanks FDA?!

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.